These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 23312788)

  • 1. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
    Koga M; Murai J; Morita S; Saito H; Kasayama S
    J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes.
    Koga M; Inada S; Nakao T; Kawamori R; Kasayama S
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27386821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
    Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
    Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.
    Takahashi S; Uchino H; Shimizu T; Kanazawa A; Tamura Y; Sakai K; Watada H; Hirose T; Kawamori R; Tanaka Y
    Endocr J; 2007 Feb; 54(1):139-44. PubMed ID: 17159300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
    Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of glycated albumin for early detection of deterioration of glycemic control state after discharge from educational admission.
    Murai J; Soga S; Saito H; Koga M
    Endocr J; 2013; 60(4):409-13. PubMed ID: 23221004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
    Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH
    Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin indicates peripheral diabetic neuropathy.
    Wang N; Guo C; Han P; Li T
    Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
    Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
    Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
    J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea.
    Shin KS; Park MS; Lee MY; Cho EH; Woo HY; Park H; Kwon MJ
    Scand J Clin Lab Invest; 2024 May; 84(3):168-173. PubMed ID: 38634263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus.
    Jung CH; Lee B; Choi DH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    Diabetes Res Clin Pract; 2017 Mar; 125():53-61. PubMed ID: 28167326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glycated albumin to HbA1c ratio is elevated in patients with fulminant type 1 diabetes mellitus with onset during pregnancy.
    Koga M; Shimizu I; Murai J; Saito H; Kasayama S; Kobayashi T; Imagawa A; Hanafusa T;
    J Med Invest; 2013; 60(1-2):41-5. PubMed ID: 23614910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus.
    Suo M; Wen D; Wang W; Zhang T
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32352504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.